Strategies for Optimizing a Mailed FIT Program in Appalachia
ConditionColonic Neoplasms
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-74
SponsorOhio State University Comprehensive Cancer Center
About this trial
The proposed study is examining strategies for optimizing mailed fecal immunochemical test (FIT) programs. In doing so, it will assess the efficacy of two promising strategies, FIT kit materials and patient navigation delivery mode. These strategies may help to improve colorectal cancer screening rates.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Resident of an Appalachian county
Medical visit at a participating health system in the past two years
Average-risk for colorectal cancer
Not currently within colorectal cancer screening guidelines
Disqualifiers
None
Trial design
Design model
Factorial
Treatments tested in this trial
Standard FIT kit
BehavioralReceive a standard FIT kit
Enhanced FIT kit
BehavioralReceive a enhanced FIT kit that includes a video brochure, disposable gloves, and a disposable stool collection device
Telephone patient navigation
BehavioralReceive telephone-based patient navigation
Text message patient navigation
BehavioralReceive text message-based patient navigation
Treatment groups
550 Participants
are divided into 4 treatment groupsGroup A: Group A (standard FIT kit plus telephone PN)Experimental treatment 2 interventions
Group B: Group B (standard FIT kit plus text message PN)Experimental treatment 2 interventions
Group C: Group C (enhanced FIT kit plus telephone PN)Experimental treatment 2 interventions
Group D: Group D (enhanced FIT kit plus text message PN)Experimental treatment 2 interventions
Trial outcomes
Primary outcomes
1
FIT Return
Proportion of participants who return of a completed FIT kit
Time frame
Within 8 weeks of FIT kit distributionSponsors and contacts
Click on the lead sponsor to view all of their trials.
Ohio State University Comprehensive Cancer Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov